These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12547)

  • 61. [Ageing and neurotransmitters].
    Nakamura S; Miyata S
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract]   [Full Text] [Related]  

  • 62. On the intracerebral origin of homovanillic acid of the cerebrospinal fluid of experimental animals.
    Papeschi R; Sourkes TL; Poirier LJ; Boucher R
    Brain Res; 1971 May; 28(3):527-33. PubMed ID: 5000053
    [No Abstract]   [Full Text] [Related]  

  • 63. gamma-Aminobutyric acid receptors in normal human brain and Huntington disease.
    Van Ness PC; Watkins AE; Bergman MO; Tourtellotte WW; Olsen RW
    Neurology; 1982 Jan; 32(1):63-8. PubMed ID: 6275305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neurochemical changes following the administration of precursors of biogenic amines.
    Smith JE; Lane JD; Shea PA; McBride WJ
    Life Sci; 1977 Aug; 21(3):301-6. PubMed ID: 19668
    [No Abstract]   [Full Text] [Related]  

  • 65. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential transmitter release from nerve terminals isolated from basal ganglia and substantia nigra.
    Hardy JA; de Belleroche JS; Border D; Bradford HF
    J Neurochem; 1980 May; 34(5):1130-9. PubMed ID: 6103020
    [No Abstract]   [Full Text] [Related]  

  • 67. Chemical neuroanatomy of the basal ganglia--normal and in Parkinson's disease.
    Hornykiewicz O
    J Chem Neuroanat; 2001 Jul; 22(1-2):3-12. PubMed ID: 11470551
    [No Abstract]   [Full Text] [Related]  

  • 68. Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture.
    Martin JB
    Neurology; 1984 Aug; 34(8):1059-72. PubMed ID: 6146951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy.
    Palomero-Gallagher N; Bidmon HJ; Cremer M; Schleicher A; Kircheis G; Reifenberger G; Kostopoulos G; Häussinger D; Zilles K
    Cell Physiol Biochem; 2009; 24(3-4):291-306. PubMed ID: 19710544
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurotransmitter systems in schizophrenia.
    Reynolds GP
    Int Rev Neurobiol; 1995; 38():305-39. PubMed ID: 8537203
    [No Abstract]   [Full Text] [Related]  

  • 71. The pharmacology of tardive dyskinesias.
    Klawans HL
    Am J Psychiatry; 1973 Jan; 130(1):82-6. PubMed ID: 4264755
    [No Abstract]   [Full Text] [Related]  

  • 72. Effect of frontal pole ablation on biogenic amine levels in the brain.
    Nielson HC
    Exp Neurol; 1966 Aug; 15(4):484-9. PubMed ID: 5911101
    [No Abstract]   [Full Text] [Related]  

  • 73. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC; Toon R; Kleinman J; Heller A
    J Neurochem; 1973 Jan; 20(1):69-80. PubMed ID: 4687208
    [No Abstract]   [Full Text] [Related]  

  • 74. Dopa as an antimetabolite in Huntington's disease.
    Baskin F; Rosenberg RN
    Lancet; 1973 Mar; 1(7803):582-3. PubMed ID: 4120646
    [No Abstract]   [Full Text] [Related]  

  • 75. Neurochemical substrates and neuroanatomical generators of the event-related P300.
    Frodl-Bauch T; Bottlender R; Hegerl U
    Neuropsychobiology; 1999; 40(2):86-94. PubMed ID: 10474063
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.
    Sitte HH; Pifl C; Rajput AH; Hörtnagl H; Tong J; Lloyd GK; Kish SJ; Hornykiewicz O
    Eur J Neurosci; 2017 Jan; 45(1):192-197. PubMed ID: 27741357
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Neurotransmitter systems in aging and senile dementia.
    McGeer EG
    Prog Neuropsychopharmacol; 1981; 5(5-6):435-45. PubMed ID: 6122227
    [No Abstract]   [Full Text] [Related]  

  • 78. Chemical pathology of Huntington's disease.
    Bird ED
    Annu Rev Pharmacol Toxicol; 1980; 20():533-51. PubMed ID: 6446256
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions.
    Herrera-Marschitz M; Loidl CF; You ZB; Andersson K; Silveira R; O'Connor WT; Goiny M
    Mol Neurobiol; 1994; 9(1-3):171-82. PubMed ID: 7888094
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neurotransmitter accumulation and calcium-dependent release from different regions of rat brain.
    Haycock JW; Meligeni JA
    Life Sci; 1977 Dec; 21(12):1837-43. PubMed ID: 24157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.